Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Market Closed
Updated:
May 15, 2024
Sourcebio International PLC
Gross Profit
|
Sourcebio International PLC
Gross Profit Peer Comparison
Comparables:
KOO
G
GENI
TLY
T
TRLS
MGP
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sourcebio International PLC
LSE:SBI
|
Gross Profit
£36.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Gross Profit
£25.9m
|
CAGR 3-Years
42%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
G
|
Genincode PLC
LSE:GENI
|
Gross Profit
£632k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Totally PLC
LSE:TLY
|
Gross Profit
£22.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Gross Profit
$19k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medica Group PLC
LSE:MGP
|
Gross Profit
£37.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
See Also
What is Sourcebio International PLC's Gross Profit?
Gross Profit
36.2m
GBP
36.2m
GBP
Based on the financial report for Dec 31, 2021, Sourcebio International PLC's Gross Profit amounts to 36.2m GBP.
What is Sourcebio International PLC's Gross Profit growth rate?
Gross Profit CAGR 3Y
51%
51%
Over the last year, the Gross Profit growth was 77%. The average annual Gross Profit growth rates for Sourcebio International PLC have been 51% over the past three years .
You don't have any saved screeners yet
